>10106H|ascrinvacumab|Homo sapiens||H-GAMMA-2 (VH (1-118) [D1] + CH1 (119-216) [D2] + CH2 (229-337) [D3] + CH3 (338-442) [D4])|||||||444|444|||MW undefined|MW undefined|
QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGEYYWNWIRQHPGKGLEWIGYIYYSGSTY
YNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARESVAGFDYWGQGTLVTVSSAS 
TKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGL 
YSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLF 
PPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVV 
SVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQV 
SLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVF 
SCSVMHEALHNHYTQKSLSLSPGK                                     
>10106L|ascrinvacumab|Homo sapiens||L-KAPPA (V-KAPPA (1-108) [D1] + C-KAPPA (109-215) [D2])|||||||215|215|||MW undefined|MW undefined|
EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGTSSRATGIP
DRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPITFGQGTRLEIKRTVAAPSVFIFP 
PSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTL 
TLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC                          
